Front Matter
Show Items
SECTION I. Magnitude/Significance of Drug-Induced Diseases: Impact on the Healthcare System
Chapter 2: Epidemiology and Public Health Impact of Drug-Induced Diseases
Chapter 3: Factors Contributing to Drug-Induced Diseases
Chapter 4: Postmarketing Surveillance for Drug-Induced Diseases
Chapter 5: Evaluating Patients for Drug-Induced Diseases
SECTION II. Drug-Induced Dermatologic Diseases
Show Items
SECTION III. Drug-Induced Neurological Diseases
Show Items
SECTION IV. Drug-Induced Psychiatric Diseases
Show Items
SECTION V. Drug-Induced Pulmonary Diseases
Show Items
SECTION VI. Drug-Induced Cardiovascular Diseases
Show Items
SECTION VII. Drug-Induced Endocrine Diseases
Show Items
SECTION VIII. Drug-Induced Gastrointestinal Diseases
Show Items
SECTION IX. Drug-Induced Diseases of the Kidney and Fluid & Electrolyte Disorders
Show Items
SECTION X. Drug-Induced Hematological Disorders
Show Items
SECTION XI. Drug-Induced Bone, Joint, and Muscle Diseases
Show Items
SECTION XII. Miscellaneous Drug-Induced Diseases
Show Items

Chapter 1: Drug Safety and Drug-Induced Diseases: The Regulatory, Legal, and Practice Environments

in Drug-Induced Diseases
Author:
Cynthia Reilly
DOI:
https://doi.org/10.37573/9781585285310.001
Restricted access